Drug Repurposing

Drug repurposing or drug repositioning is a new approach to presenting new indications for common commercial and clinically approved existing drugs. For example, chloroquine, an old antimalarial drug, showed promising results for treating COVID-19, interfering with MDR in several types of cancer, an...

Description complète

Enregistré dans:
Détails bibliographiques
Format: Online
Langue:anglais
Publié: IntechOpen 2021
Sujets:
Accès en ligne:ONIX_20210420_9781839685217_3136
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1869518015411781632
collection Directory of Open Access Books
description Drug repurposing or drug repositioning is a new approach to presenting new indications for common commercial and clinically approved existing drugs. For example, chloroquine, an old antimalarial drug, showed promising results for treating COVID-19, interfering with MDR in several types of cancer, and chemosensitizing human leukemic cells.This book focuses on the hypothesis, risk/benefits, and economic impacts of drug repurposing on drug discovery in dermatology, infectious diseases, neurological disorders, cancer, and orphan diseases. It brings together up-to-date research to provide readers with an informative, illustrative, and easy-to-read book useful for students, clinicians, and the pharmaceutical industry.
format Online
id doab-20.500.12854ir-67776
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher IntechOpen
publisherStr IntechOpen
record_format ojs
spelling doab-20.500.12854ir-677762024-04-01T14:14:52Z Drug Repurposing Badria, Farid A. Pharmacology thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology Drug repurposing or drug repositioning is a new approach to presenting new indications for common commercial and clinically approved existing drugs. For example, chloroquine, an old antimalarial drug, showed promising results for treating COVID-19, interfering with MDR in several types of cancer, and chemosensitizing human leukemic cells.This book focuses on the hypothesis, risk/benefits, and economic impacts of drug repurposing on drug discovery in dermatology, infectious diseases, neurological disorders, cancer, and orphan diseases. It brings together up-to-date research to provide readers with an informative, illustrative, and easy-to-read book useful for students, clinicians, and the pharmaceutical industry. 2021-04-20T16:25:26Z 2021-04-20T16:25:26Z 2020 book ONIX_20210420_9781839685217_3136 9781839685217 9781839685200 9781839685224 https://directory.doabooks.org/handle/20.500.12854/67776 eng image/jpeg n/a https://www.intechopen.com/books https://mts.intechopen.com/storage/books/9086/authors_book/authors_book.pdf IntechOpen IntechOpen 10.5772/intechopen.83082 10.5772/intechopen.83082 78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6 9781839685217 9781839685200 9781839685224 IntechOpen 234 open access
spellingShingle Pharmacology
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
Drug Repurposing
title Drug Repurposing
title_full Drug Repurposing
title_fullStr Drug Repurposing
title_full_unstemmed Drug Repurposing
title_short Drug Repurposing
title_sort drug repurposing
topic Pharmacology
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
topic_facet Pharmacology
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
url ONIX_20210420_9781839685217_3136